| Name | Title | Contact Details |
|---|---|---|
Mark Finkle |
VP of Engineering (Productivity & Developer Program) | Profile |
Builders Benefits Inc is a Latham, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Your doctor’s office is now online. From primary care to mental health, we’ve got you covered.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Gallus Biopharmaceuticals is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Cortland Acres community offers a variety of housing choices to meet the needs of active older adults.